This inventor holds 0 USPTO granted patents, plus 5 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Roland Rupp: Innovator in Pharmaceutical Treatments
Introduction
Roland Rupp is a notable inventor based in Germany, recognized for his contributions to pharmaceutical innovations. He has focused on developing effective treatments for complex medical conditions, particularly multiple sclerosis and Parkinson's disease. Despite having no patents registered under his name, his work has significantly impacted the field of medicine.
Latest Patents
Rupp's latest inventions include a method for treating multiple sclerosis through a combination therapy. This method involves administering a single oral dosage form of dimethylfumarate along with one of the following agents: teriflunomide, fingolimod, or laquinimod. This combination is designed to be more effective than single agents alone, offering reduced side effects and better tolerability. Additionally, he has developed a solid pharmaceutical preparation containing (R)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chroman, which is intended for the treatment of dyskinesia associated with Parkinson's disease. This preparation includes sugar alcohols as fillers and boasts an increased shelf life, even at elevated temperatures.
Career Highlights
Throughout his career, Rupp has worked with several prominent companies, including FWP IP Aps and Merck Patent Gesellschaft mit beschränkter Haftung. His experience in these organizations has allowed him to refine his skills in pharmaceutical development and innovation.
Collaborations
Rupp has collaborated with notable professionals in the field, including Theis Terwey and Peder M. Andersen. These partnerships have contributed to the advancement of his research and the effectiveness of his inventions.
Conclusion
Roland Rupp's work in pharmaceutical innovations demonstrates his commitment to improving treatment options for patients with challenging medical conditions. His contributions, particularly in combination therapies, highlight the importance of collaboration and innovation in the field of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile